Laryngeal mucous membrane pemphigoid serves as a prognostic factor for poor response to treatment with rituximab.

In Dermatology
by ClinOwl

Mucous Membrane Pemphigoid (MMP) comprises a group of auto-antibody mediated subepidermal bullous diseases characterized by predominant involvement of mucous membranes and a tendency to scarring. Rituximab (RTX) has emerged as a […]